Using a genetically modified Alk7-/- mouse model, we demonstrated for the first time that endogenous ALK7 expression in ventricular cardiomyocyte was necessary to prevent QT interval prolongation, maintain normal APD and protect against ventricular arrhythmia. This evidence concerns the gene ACVR1C and Ventricular arrhythmia.